<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05020405</url>
  </required_header>
  <id_info>
    <org_study_id>KD/21/20</org_study_id>
    <nct_id>NCT05020405</nct_id>
  </id_info>
  <brief_title>The Effect of Simvastatin With Guided Bone Regeneration in Ridge Splitting and Simultaneously Implantation</brief_title>
  <official_title>The Effect of Simvastatin With Guided Bone Regeneration on Ridge Volume in Ridge Splitting and Simultaneously Implantation: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kafrelsheikh University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kafrelsheikh University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ridge split augmentation technique, with immediate implant placement, reduces the time of the&#xD;
      treatment and the time of the final prosthetic reconstruction. Furthermore, compression of&#xD;
      the bone increases its density. SMV is also found to promote osteogenic differentiation of&#xD;
      bone marrow stem cells, suppress osteoclastic differentiation in bone tissue, and promotes&#xD;
      osseointegration around implants in animal studies. The aim of this study is to compare&#xD;
      surgical outcomes of the application of the alveolar ridge splitting (ARS) in combination&#xD;
      with guided bone regeneration (GBR) using bone grafting and a barrier membrane, associated&#xD;
      with immediate implant placement versus ARS in combination with the use of SMV with GBR using&#xD;
      bone grafting and a barrier membrane, associated with immediate implant placement in patients&#xD;
      with horizontally atrophic jaw bones.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurements of the amount of bone formation in millimeters around immediately placed dental implants</measure>
    <time_frame>9 months</time_frame>
    <description>Measurements of the amount of bone formation in millimeters using GBR with or without the combined effect of SMV in the ridge splitting following immediate implant placement.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Ridge Splitting</condition>
  <condition>Simvastatin</condition>
  <condition>Immediate Implant</condition>
  <arm_group>
    <arm_group_label>ARS with GBR and SMV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>alveolar ridge splitting in combination with the use of GBR with SMV with immediate implant placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alveolar ridge splitting with GBR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>alveolar ridge splitting in combination with the use of GBR without SMV with immediate implant placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immediate implant placement and ARS with GBR and SMV</intervention_name>
    <description>Implant insertion and GBR for augmentation of the gap between buccal and lingual plate using bone graft mixed with SMV</description>
    <arm_group_label>ARS with GBR and SMV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immediate implant placement and ARS with GBR</intervention_name>
    <description>Implant insertion and GBR for augmentation of the gap between buccal and lingual plate</description>
    <arm_group_label>alveolar ridge splitting with GBR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  good general health at the time of surgery.&#xD;
&#xD;
          -  at least 3 months of healing after tooth extraction.&#xD;
&#xD;
          -  horizontally compromised alveolar ridges at least 10 mm high and 3 mm wide.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  a vertical bone defect in the edentulous ridge.&#xD;
&#xD;
          -  thick cortex in the labial/buccal with less cancellous bone inside&#xD;
&#xD;
          -  obvious undercut on the labial/buccal side.&#xD;
&#xD;
          -  uncontrolled periodontal conditions or other oral disorders.&#xD;
&#xD;
          -  history of radiotherapy in the head and neck region.&#xD;
&#xD;
          -  uncontrolled diabetes mellitus or other systematic disorders.&#xD;
&#xD;
          -  smokers.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  non-compliant patients.&#xD;
&#xD;
          -  allergic reaction to the medications used.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dalia R Issa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kafrelsheikh University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry, Kafrelsheikh University</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <zip>33511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 18, 2021</study_first_submitted>
  <study_first_submitted_qc>August 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kafrelsheikh University</investigator_affiliation>
    <investigator_full_name>Dalia Rasheed Issa</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

